Status:
TERMINATED
OxyPrem Validation Study
Lead Sponsor:
Hans Ulrich Bucher
Conditions:
Tissue Oxygenation Measurement
Eligibility:
All Genders
Phase:
NA
Brief Summary
The precision of the novel diagnostic near-infrared spectroscopy (NIRS) device for the measurement of tissue oxygenation and hemoglobin concentration (OxyPrem) is assessed by repeated measurements. Th...
Eligibility Criteria
Inclusion
- Substudy 1 (healthy adult volunteers)
- Healthy adult
- Signed informed consent
Exclusion
- Dense black hair at the location of measurement
- Neurological diseases.
- Substudy 2 (preterm infants)
- Inclusion Criteria:
- Pre-term neonates (gestational age at birth less than 37 weeks)
- Signed informed consent by at least one parent
Key Trial Info
Start Date :
August 4 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 21 2022
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT04860401
Start Date
August 4 2010
End Date
June 21 2022
Last Update
July 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Zurich
Zurich, Canton of Zurich, Switzerland, 8091